Compugen Stock Market Value
| CGEN Stock | USD 1.65 0.02 1.20% |
| Symbol | Compugen |
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.
Compugen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Compugen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Compugen.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Compugen on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Compugen or generate 0.0% return on investment in Compugen over 90 days. Compugen is related to or competes with Innate Pharma, Nuvectis Pharma, Molecular Partners, Milestone Pharmaceuticals, Rani Therapeutics, Cardiff Oncology, and Cassava Sciences. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes ... More
Compugen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Compugen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Compugen upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.57 | |||
| Information Ratio | 0.0083 | |||
| Maximum Drawdown | 23.25 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 6.57 |
Compugen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Compugen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Compugen's standard deviation. In reality, there are many statistical measures that can use Compugen historical prices to predict the future Compugen's volatility.| Risk Adjusted Performance | 0.0282 | |||
| Jensen Alpha | 0.1387 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0097 | |||
| Treynor Ratio | (0.13) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Compugen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Compugen February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0282 | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 2.96 | |||
| Semi Deviation | 3.25 | |||
| Downside Deviation | 3.57 | |||
| Coefficient Of Variation | 4020.86 | |||
| Standard Deviation | 4.21 | |||
| Variance | 17.74 | |||
| Information Ratio | 0.0083 | |||
| Jensen Alpha | 0.1387 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0097 | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 23.25 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 6.57 | |||
| Downside Variance | 12.78 | |||
| Semi Variance | 10.54 | |||
| Expected Short fall | (3.77) | |||
| Skewness | 1.07 | |||
| Kurtosis | 2.46 |
Compugen Backtested Returns
As of now, Compugen Stock is very risky. Compugen secures Sharpe Ratio (or Efficiency) of 0.0249, which signifies that the company had a 0.0249 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Compugen, which you can use to evaluate the volatility of the firm. Please confirm Compugen's Mean Deviation of 2.96, risk adjusted performance of 0.0282, and Downside Deviation of 3.57 to double-check if the risk estimate we provide is consistent with the expected return of 0.1%. Compugen has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.73, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Compugen are expected to decrease at a much lower rate. During the bear market, Compugen is likely to outperform the market. Compugen right now shows a risk of 4.21%. Please confirm Compugen total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if Compugen will be following its price patterns.
Auto-correlation | 0.22 |
Weak predictability
Compugen has weak predictability. Overlapping area represents the amount of predictability between Compugen time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Compugen price movement. The serial correlation of 0.22 indicates that over 22.0% of current Compugen price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Pair Trading with Compugen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will appreciate offsetting losses from the drop in the long position's value.Moving together with Compugen Stock
Moving against Compugen Stock
| 0.54 | HBIO | Harvard Bioscience | PairCorr |
| 0.44 | OSL | Oncosil Medical Earnings Call This Week | PairCorr |
| 0.4 | CDT | Conduit Pharmaceuticals | PairCorr |
| 0.33 | GSS | Genetic Signatures Earnings Call Next Week | PairCorr |
The ability to find closely correlated positions to Compugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugen to buy it.
The correlation of Compugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Compugen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Compugen Correlation, Compugen Volatility and Compugen Performance module to complement your research on Compugen. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Compugen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.